Online Courses

NMT/RT Part 2: Endocrine Anatomy & Physiology

Price: $8.00
Imaging CE: 1.00
This course is accessible until 9/30/2024

This course is part of the Anatomy and Physiology Review for NMT/RT. The endocrine system is the body's network of specialized glands that secrete minute amounts of chemical messengers, called hormones. Working in concert with the nervous system to regulate and coordinate basic body functions, endocrine hormones influence almost every cell, tissue, and organ to influence the way we feel and act. A&P for NMT/RT is designed to give an overview/review of the endocrine system with an emphasis on assessment, treatment and care of the patient with endocrine disorders most commonly encountered: Syndrome of inappropriate antidiuretic hormone, adrenal insufficiency, pheochromocytoma, Cushing's Syndrome, Addison's Disease, and hypoparathyroidism.

This content is supported by 6 addition anatomy and physiology courses for NMT/RT: Cardiovascular, Gastrointestinal, Hematology, Neurology, Pulmonary, and Renal.

NOTE for Imaging: This activity may be available in multiple formats or from different sponsors; individuals may not repeat and report a self-learning activity for credit twice in the same biennium. You must be licensed in the state of Florida to report an activity that is only approved by the state. If this activity is also approved by an organization that ARRT has approved to evaluate CE, select that organization’s name, as opposed to the state licensing agency name.

This course reports to CE Broker
Upon successful completion of this course, the participant will be able to:
  1. Describe the anatomy and physiology of the endocrine system, including the function of various hormones and associated physiological effects.
  2. Compare the pathophysiology, clinical manifestations, diagnostics, treatment, and nursing care management of a patient with syndrome of inappropriate antidiuretic hormone to those of a patient with diabetes insipidus.
  3. Identify the etiology and the signs and symptoms of a patient with Cushing's syndrome and describe the diagnostics and treatments used.
  4. Identify the etiology and the signs and symptoms of a patient with a pheochromocytoma and describe the diagnostics and treatments used.
  5. Identify the etiology and the signs and symptoms of a patient with hyperthyroid crisis and myxedema coma and describe the diagnostics and treatments used for each.
  6. Identify the etiology and the signs and symptoms of a patient with hypoparathyroidism and describe the diagnostics and treatments used.

Qualified Planners/Faculty

Revisioning Author: Sydney Moran, PhD, RN, CPN

Sydney Moran is an Assistant Professor in the Department of Nursing at AdventHealth University. She teaches in Health Assessment, Health Promotion, and Pediatrics. She has been a Registered Nurse for 25 years. She received her ASN from Valencia Community College; BSN from Florida Hospital College of Health Sciences; MSN from University of Central Florida; PhD from Barry University. Dr. Moran specialized in Pediatric Medical-Surgical nursing. She is a Certified Pediatric Nurse and member of the Society of Pediatric Nurses. Currently she serves as the secretary for AHU's Chapter of Sigma Theta Tau International Nursing Honor Society, Chi Upsilon. Her research areas of interest are videoconferencing technologies, student perspectives, and workplace environment.


This author has disclosed that there are neither conflicts of interest nor commercial affiliation with this activity.

Matthew J Wren, MSN, RN, AGCNS-BC, CEN

Matthew Wren received his Masters of Science in Nursing from the University of South Alabama in 2014.  He is currently the Senior Nurse Manager for the Glycemic Program at AdventHealth in Orlando Florida. Mr. Wren is also a member of the Ethics Committee Triage team and serves as Campus Liaison and Subject Matter Expert for glycemic management, CAUTI, restraints, sepsis, insulin pump therapy and Endotool.

This author has disclosed that there are neither conflicts of interest nor commercial affiliation with this activity.

- 9/30/2024
2001 K Street, NW
Suite 300 North
Washington, DC 20006
Phone: 800-334-2472
CE Credits: 1.00, Category: END1345 = A ARRT, Expires: 9/30/2024
CE Credits: 1.00, Category: FLDOH-BRC = Cat A/Technical Approved, Expires: 1/31/2026

Completion Requirements: To receive continuing education credit commensurate with the credit awarded for this on-line activity, the participant must:

  • View all modules and cases studies.
  • Participate and pass all Self-Checks and Post Test(s).
  • Complete and submit the on-line evaluation.

Certificates of Completion: will be available to print immediately upon finishing the completion requirements. You are encouraged to print and save your certificate for your portfolio as required by your licensing body. Interdisciplinary accredited activities, activities having multiple accreditors, will be listed individually on the Certificate of Completion.

Non-Endorsement of Products: echelon®, as an accredited provider, has demonstrated proficient experience and viable resources to provide for valid and reliable evaluation of CE activities. The accuracy of the facts and opinions contained in this activity are the responsibility of the author(s) and do not necessarily reflect those of echelon® or its sponsors. Practitioners should consult primary resources, state regulations, and their healthcare facility policies and procedures for specific application of said content to their local situation. echelon® does not imply that there is real or implied endorsement of any product, service, or company neither referred to in this activity nor of any company subsidizing costs related to this activity. All information contained in this activity is for educational purposes only.

Electronic Record Retention: All activity records are kept on file for a minimum of six (6) years.

Relevant Financial Relationships: echelon® also chooses full disclosure with each activity to report any relevant financial relationship affiliation or support in conjunction with the planning or development of any activity.

*There are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this activity.